Opportunity Information: Apply for RFA IP 12 006
Apply for RFA IP 12 006
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infections in Panama and Central America Region" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Dec 21, 2011 and posted on Dec 21, 2011.
- Applicants must submit their applications by Feb 14, 2012 by 500 PM U.S. Eastern Time. On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM U.S. Eastern Time. Note HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility is limited to the Gorgas Memorial Institute for Health Studies (GMI) in Panama and the countries of Central America regio
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infections in Panama and Central America Region" (Funding Opportunity Number RFA IP 12 006), was a CDC discretionary funding announcement issued by the Centers for Disease Control and Prevention under CFDA 93.283 (CDC Investigations and Technical Assistance). It used a cooperative agreement mechanism, meaning the CDC expected to have substantial involvement in the work alongside the awardee rather than acting only as a passive funder. The activity area was health, and the program was positioned within the National Center for Immunization and Respiratory Diseases (NCIRD), specifically the Influenza Division.
The central goal was to build and strengthen regional capacity in Panama and the Central America region to better detect and characterize influenza as well as other emerging and re-emerging infectious diseases of public health importance, with a strong emphasis on respiratory infections. The opportunity focused on improving the ability to identify cases and outbreaks, describe patterns of disease, and conduct studies that explain how influenza and similar pathogens spread. In practical terms, the work envisioned would support stronger surveillance and epidemiologic investigation, with the intent of producing clearer, more actionable pictures of transmission dynamics, disease severity, and who is most affected.
A major component of the program was generating evidence on the burden of disease. That included not only clinical and epidemiologic burden (such as incidence, hospitalization, and mortality patterns), but also economic burden, reflecting the costs to health systems and societies. By emphasizing economic burden, the announcement signaled an interest in data that can inform policy choices, budgeting, and prioritization of interventions, especially in settings where resources are limited and tradeoffs are unavoidable.
Another key aim was evaluation of interventions and tools that could improve prevention or treatment outcomes. The announcement explicitly referenced evaluating new diagnostics, vaccines, risk assessment methods, and other interventions. That framing suggests support for applied public health research and field evaluation, such as assessing how well new or improved diagnostic approaches perform in real-world clinical or surveillance settings, examining vaccine-related strategies, and testing methods that help public health authorities better anticipate risk and respond more effectively. The overall direction was to move beyond basic detection and toward evidence-driven decisions about which tools and approaches meaningfully reduce illness and its impact.
Eligibility was restricted: the only eligible applicant was the Gorgas Memorial Institute for Health Studies (GMI). In effect, this was a targeted funding opportunity intended to establish or continue a formal collaboration between CDC and GMI to serve as a regional hub or key partner for influenza and respiratory disease epidemiology and related evaluations across Panama and Central America. The announcement anticipated a single award (Expected Awards: 1), reinforcing that this was designed as a focused partnership rather than a broad competition.
From an administrative standpoint, the announcement was posted on December 21, 2011, with an application deadline of February 14, 2012 at 5:00 PM U.S. Eastern Time, and it was archived on February 15, 2012. The application process required electronic submission through Grants.gov and validation through eRA Commons by the deadline, with an explicit warning that there would be no post-deadline error-correction window under CDC/HHS procedures. The estimated total funding amount listed was $5,000,000, and there was no cost sharing or matching requirement. Award ceiling and floor were both listed as 0, which typically indicates the specific award amount was handled in the full announcement or would be determined through negotiation and available appropriations rather than being constrained by a simple stated range in that summary field.
Overall, the opportunity was designed to strengthen regional public health readiness and scientific capacity for influenza and other important respiratory threats by combining surveillance strengthening, epidemiologic and economic burden studies, and evaluation of practical tools like diagnostics and vaccines. The cooperative agreement structure underscored CDCs intent to collaborate closely with GMI to produce results that can guide prevention, preparedness, and response efforts across Panama and Central America.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infections in Panama and Central America Region."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA IP 12 006.
Which federal agency issued this funding announcement?
The funding announcement was issued by the Centers for Disease Control and Prevention (CDC).
What is the CFDA number associated with this opportunity?
The CFDA number is 93.283, listed as "CDC Investigations and Technical Assistance."
What type of funding mechanism is being used?
This opportunity used a cooperative agreement mechanism. That means CDC anticipated substantial involvement in the work alongside the awardee, rather than acting only as a passive funder.
What is the main activity area or focus area?
The activity area is health, with a focus on influenza and other respiratory infections in Panama and the Central America region.
Which CDC center/division administered or positioned this program?
The program was positioned within CDC's National Center for Immunization and Respiratory Diseases (NCIRD), specifically the Influenza Division.
What is the overall goal of the grant?
The central goal was to build and strengthen regional capacity in Panama and the Central America region to better detect and characterize influenza and other emerging and re-emerging infectious diseases of public health importance, with a strong emphasis on respiratory infections.
What kinds of capabilities was the program intended to strengthen?
The program emphasized improving the ability to identify cases and outbreaks, describe patterns of disease, and conduct studies that explain how influenza and similar pathogens spread. It also envisioned stronger surveillance and epidemiologic investigation to produce clearer, more actionable pictures of transmission dynamics, disease severity, and who is most affected.
Does the opportunity address diseases beyond influenza?
Yes. While influenza is central, the opportunity also referenced "other respiratory infections" and other emerging and re-emerging infectious diseases of public health importance, with emphasis on respiratory threats.
What does the opportunity say about studying disease burden?
A major component was generating evidence on the burden of disease, including clinical and epidemiologic burden (such as incidence, hospitalization, and mortality patterns) and economic burden (costs to health systems and societies).
Why is economic burden mentioned as part of the program?
The emphasis on economic burden signaled interest in data that can inform policy choices, budgeting, and prioritization of interventions, especially in settings where resources are limited and tradeoffs are unavoidable.
What kinds of interventions or tools were expected to be evaluated?
The announcement explicitly referenced evaluating new diagnostics, vaccines, risk assessment methods, and other interventions intended to improve prevention or treatment outcomes.
What is meant by evaluating diagnostics, vaccines, or risk assessment methods?
Based on the announcement framing, it suggests applied public health research and field evaluation, such as assessing how diagnostic approaches perform in real-world clinical or surveillance settings, examining vaccine-related strategies, and testing methods that help public health authorities anticipate risk and respond more effectively.
Was this a competitive opportunity open to many applicants?
No. Eligibility was restricted to a single eligible applicant.
Who was eligible to apply?
The only eligible applicant was the Gorgas Memorial Institute for Health Studies (GMI).
How many awards were expected?
The announcement anticipated a single award (Expected Awards: 1).
What does the expected single award suggest about the program design?
It indicates the opportunity was designed as a focused, targeted partnership rather than a broad competition, and it was intended to establish or continue formal collaboration between CDC and GMI as a regional hub or key partner.
When was the opportunity posted?
The announcement was posted on December 21, 2011.
What was the application deadline?
The application deadline was February 14, 2012 at 5:00 PM U.S. Eastern Time.
When was the opportunity archived?
The opportunity was archived on February 15, 2012.
How were applications required to be submitted?
The application process required electronic submission through Grants.gov and validation through eRA Commons by the deadline.
Was there an opportunity to correct submission errors after the deadline?
No. The announcement included an explicit warning that there would be no post-deadline error-correction window under CDC/HHS procedures.
What was the estimated total funding amount?
The estimated total funding amount listed was $5,000,000.
Was cost sharing or matching required?
No. The announcement stated there was no cost sharing or matching requirement.
Were award floor and ceiling amounts specified?
Award ceiling and floor were both listed as 0. This typically indicates the specific award amount was handled in the full announcement or would be determined through negotiation and available appropriations rather than being constrained by a stated range in the summary.
What is the geographic scope of the work described?
The opportunity focused on Panama and the Central America region.
What is the intended public health impact of this cooperative agreement?
Overall, the opportunity was designed to strengthen regional public health readiness and scientific capacity for influenza and other important respiratory threats by combining surveillance strengthening, epidemiologic and economic burden studies, and evaluation of practical tools like diagnostics and vaccines. The cooperative agreement structure underscored CDC's intent to collaborate closely with GMI to produce results that can guide prevention, preparedness, and response efforts across Panama and Central America.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: International Sports Programming Initiative (ISPI)
Previous opportunity: Studies at the Animal Human Interface of Influenza and Other Zoonotic Diseases in Vietnam
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 12 006
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 12 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 12 009 Funding Number: RFA NS 12 009 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Research Dissemination and Implementation Grants (R18) Apply for PAR 12 063 Funding Number: PAR 12 063 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Public Health Conference Support Program Apply for CDC RFA EH12 1201 Funding Number: CDC RFA EH12 1201 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Research Grants for Preventing Violence and Violence Related Injury Apply for RFA CE 12 002 Funding Number: RFA CE 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Identifying Modifiable Protective Factors for Intimate Partner Violence or Sexual Violence Prevention Apply for RFA CE 12 003 Funding Number: RFA CE 12 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Regional Genetic and Newborn Screening Services Collaboratives Heritable Disorders Program Apply for HRSA 12 138 Funding Number: HRSA 12 138 Agency: Health Resources and Services Administration Category: Health Funding Amount: $600,000 |
| Healthy Start Initiative Eliminating Disparities in Perinatal Health (General Population) Apply for HRSA 12 016 Funding Number: HRSA 12 016 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Healthy Start Initiative Eliminating Disparities in Perinatal Health (Border, Alaska, and Hawaii) Apply for HRSA 12 017 Funding Number: HRSA 12 017 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Green Housing Study Follow up Measurements of Housing Factors and Respiratory Health of Children located in Cincinnati and Boston (U01) Apply for RFA EH 12 001 Funding Number: RFA EH 12 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| HIV Early Intervention Services (EIS) Program Existing Geographic Service Areas (EISEGA) Apply for HRSA 12 076 Funding Number: HRSA 12 076 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Reducing Health Disparities among People with Intellectual Disabilities Apply for RFA DD 12 003 Funding Number: RFA DD 12 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Service Area Competition Additional Areas (Boydton, VA) Apply for HRSA 12 168 Funding Number: HRSA 12 168 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Systems of Services for Children and Youth with Special Health Care Needs (CYSHCN) Apply for HRSA 12 049 Funding Number: HRSA 12 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| New England Region AIDS Education and Training Center Program(s) (AETC) Apply for HRSA 12 124 Funding Number: HRSA 12 124 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Network and Infrastructure Support for Development of Interdisciplinary Aging Research (R24) Apply for PA 12 064 Funding Number: PA 12 064 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Heredity and Health in Africa (H3Africa) H3Africa Biorepository Grants (UH2/UH3) Apply for RFA RM 12 003 Funding Number: RFA RM 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $115,000 |
| HIV Innovations for Improved Patient Outcomes for Priority Populations Apply for 674 12 000003 Funding Number: 674 12 000003 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $15,000,000 |
| Public Health Traineeships Apply for HRSA 12 005 Funding Number: HRSA 12 005 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Faculty Development in General, Pediatric, and Public Health Dentistry and Dental Hygiene Apply for HRSA 12 109 Funding Number: HRSA 12 109 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Training Programs for Critical HIV Research Infrastructure for Low and Middle Income Country Institutions (G11) Apply for PAR 12 069 Funding Number: PAR 12 069 Agency: National Institutes of Health Category: Health Funding Amount: $92,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 12 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.